In today’s briefing:
- Meihua International Medical Technologies Pre-IPO: Risks Overshadow Cheap Valuation
Meihua International Medical Technologies Pre-IPO: Risks Overshadow Cheap Valuation
- China-Based medical devices company, Meihua International Medical Technologies intends to raise $50 million from its U.S. IPO by offering 5 million shares at price between $9 and $11 per share.
- Upon the completion of this offering, the company will have 25 million shares outstanding. At the midpoint of offer price, Meihua will command a market capitalization of $250 million.
- Despite attractive valuation, investors can avoid the IPO due to its unimpressive financial performance and concerns over Chinese companies listing in the U.S. market.
Before it’s here, it’s on Smartkarma
